BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11940379)

  • 1. Overexpression of type I growth factor receptors in pterygium.
    Liu Z; Xie Y; Zhang M
    Chin Med J (Engl); 2002 Mar; 115(3):418-21. PubMed ID: 11940379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The abnormal expression of epidermal growth factor receptor family in pterygium].
    Liu Z; Xie Y; Zhang M; Pflugfelder SC
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):372-4, 25. PubMed ID: 11853633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia.
    Liu Z; Carvajal M; Carraway CA; Carraway K; Pflugfelder SC
    Cornea; 2001 Jan; 20(1):81-5. PubMed ID: 11189010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
    Piepkorn M; Predd H; Underwood R; Cook P
    Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
    Chen X; Yeung TK; Wang Z
    Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
    Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
    Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
    Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
    Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E; Calvo JC
    J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
    Røtterud R; Nesland JM; Berner A; Fosså SD
    BJU Int; 2005 Jun; 95(9):1344-50. PubMed ID: 15892828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.
    Rajkumar T; Stamp GW; Pandha HS; Waxman J; Gullick WJ
    J Pathol; 1996 Aug; 179(4):381-5. PubMed ID: 8869284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
    Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
    Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-erbB receptors and ligands in human nasal epithelium.
    Polosa R; Prosperini G; Tomaselli V; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2000 Dec; 106(6):1124-31. PubMed ID: 11112896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
    Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca.
    Liu Z; Carvajal M; Carothers Carraway CA; Carraway KL; Pflugfelder SC
    Am J Ophthalmol; 2000 Apr; 129(4):472-80. PubMed ID: 10764856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
    Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
    Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
    Wobus M; Kuns R; Wolf C; Horn LC; Köhler U; Sheyn I; Werness BA; Sherman LS
    Gynecol Oncol; 2001 Nov; 83(2):227-34. PubMed ID: 11606076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB3 mRNA expression correlated with specific clinicopathologic features of Japanese lung cancers.
    Kawano O; Sasaki H; Endo K; Suzuki E; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    J Surg Res; 2008 May; 146(1):43-8. PubMed ID: 17631905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.